Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin versus Fibrovein for venous malformations
2011-001455-37Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Jun 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in venous malformation (VM) comparing Bleomycin with Fibrovein (2 arms). Started Jun 2011; status: completed.
02
Drugs
bleomycinsodium tetradecyl sulfate
03
Conditions
venous malformation (VM)
Beyond the preview
Go deeper on 2011-001455-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001455-37.